Congratulations to Dan Bobo (lead author), Kye Robinson, Jiaul Islam and A/Prof Kris Thurecht (UQ collaborator) on a recently accepted review article highlighting the state-of-the-art in FDA-approved nanoparticle therapeutics. The authors also summarised statistics on nanoparticles in clinical trials, and then provided an overview of the different nanoparticle classes under investigation. The article will soon be available in a special theme issue of Pharm Res.